About this PT-141 field notebook

What this project is

PT-141 Pharmacy is an independent editorial project that publishes summaries of the peer-reviewed research literature and the approved prescribing label on PT-141 (bremelanotide). We are not a clinic. We do not employ clinicians, and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The approach is that of a field notebook — a careful observer recording what the studies actually measured, in plain language, with the source attached. We keep the technical depth and add an accessible layer on top of it; we do not dilute one to reach the other.

About the "pharmacy" in the name

The word "pharmacy" in this site's name is editorial framing, not a description of services. It signals the register we write in — the availability, compounding, and approved-label context around a real prescription drug — a position this publisher occupies relative to the literature. It is not a claim that the site is a pharmacy, dispenses medication, fills prescriptions, or employs pharmacists. It does none of those things. We have no counter, no inventory, and no checkout.

How we handle evidence

We separate two layers and never blur them. The first is cited clinical evidence — every quantitative claim carries a number that resolves to a study or the FDA label on the references page. The second is community observation — the things people report from outside the trials, collected in one clearly-labeled place and attached to no journal. We flag conference abstracts as a lower evidence tier than peer-reviewed full text, and we cite the disputed 2008 erectile-dysfunction study only alongside the 2023 Expression of Concern issued against it. When the evidence is precise we are precise; when it is contested we say so.

What we do not do

We do not recommend a dose for any individual. We do not endorse PT-141, and we do not discourage its study. We report what the literature contains and what the label states, and we leave clinical decisions to qualified prescribers and the people they advise. There is no real person presented here as a founder or clinician, because none stands behind a recommendation — the project is editorial, and it speaks only for the published record it summarizes.